Stay up to date on the latest news and tweets of the Pereira Lab!
The Pereira Lab was Awarded an ERC Proof of Concept Grant
The Pereira Lab was today announced as the receiver of a Proof of Concept Grant from the European Research Council (ERC).
The Pereira Lab Was Awarded the NovoNordisk Distinguished Innovator Grant
The Pereira Lab has been awarded with a grant of 6.000.000 DKK from the NovoNordisk foundation.
Diogo Cabral Awarded a Maria de Sousa PhD Studentship From The Foundation for Science and Technology
Pereira Lab researcher Diogo Cabral was awarded a Maria de Sousa PhD Studentship by the Portuguese Foundation for Science and Technology (FCT).
3 Members of the Pereira Lab Awarded Grants from the Royal Physiographic Society of Lund
Pereira Lab PhD student Rita Alves and postdoctoral fellows Ilia Kurochkin and Camila Vasquez were each awarded a grant from the Royal Physiographic Society of Lund.
Filipe Pereira Appointed Professor at Lund University
Pereira Lab group leader Filipe Pereira has been appointed Professor of Molecular Medicine, Regeneration, Transplantation and Repair in the Hematopoietic System at Lund University.
Camila Vazquez Echegaray Awarded a MSCA Postdoctoral Fellowship
Pereira Lab researcher Camila Vazquez Echegaray was awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship.
Eurostars-funded REPRINT Project Kick-off Meeting
The Pereira Lab took part in a meeting held by Asgard Therapeutics AB, together with consortium members InSphero and Antineo, that sets the official kick-off to the earlier announced Eurostars project.
Encoding Human Dendritic Cell Fate
PU.1, IRF8, and BATF3 cooperation and role in inflammatory signaling during programming of human cDC1-like cells was uncovered at the Pereira Lab.
Spin-off From Pereira Lab Raises 6M Euros to Advance In vivo DC Reprogramming
Asgard Therapeutics AB, a private biotech company spin off from the Pereira Lab, announces the completion of a EUR 6 million seed financing round. The financing was co-led by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.
Fábio Rosa Defended His PhD Thesis
On June 10th 2021, Fábio Rosa defended his thesis “Generating Dendritic Cells by Direct Cell Reprogramming. Merging cellular reprogramming with immunology towards the development of novel cancer immunotherapies.” with Prof. Thomas Graf from the Center for Genomic Regulation (Spain) as opponent.